Protein structures which form fibrils have recently been shown to absorb light at energies in the near UV range and to exhibit a structure-specific fluorescence in the visible range even in the absence of aromatic amino acids. However, the molecular origin of this phenomenon has so far remained elusive. Here, we combine ab initio molecular dynamics simulations and fluorescence spectroscopy to demonstrate that these intrinsically fluorescent protein fibrils are permissive to proton transfer across hydrogen bonds which can lower electron excitation energies and thereby decrease the likelihood of energy dissipation associated with conventional hydrogen bonds. The importance of proton transfer on the intrinsic fluorescence observed in protein fibrils is signified by large reductions in the fluorescence intensity upon either fully protonating, or deprotonating, the fibrils at pH = 0 or 14, respectively. Thus, our results point to the existence of a structure-specific fluorophore that does not require the presence of aromatic residues or multiple bond conjugation that characterize conventional fluorescent systems. The phenomenon may have a wide range of implications in biological systems and in the design of self-assembled functional materials.
Alpha-synuclein is known to bind to small unilamellar vesicles (SUVs) via its N terminus, which forms an amphipathic alpha-helix upon membrane interaction. Here we show that calcium binds to the C terminus of alpha-synuclein, therewith increasing its lipid-binding capacity. Using CEST-NMR, we reveal that alpha-synuclein interacts with isolated synaptic vesicles with two regions, the N terminus, already known from studies on SUVs, and additionally via its C terminus, which is regulated by the binding of calcium. Indeed, dSTORM on synaptosomes shows that calcium mediates the localization of alpha-synuclein at the pre-synaptic terminal, and an imbalance in calcium or alpha-synuclein can cause synaptic vesicle clustering, as seen ex vivo and in vitro. This study provides a new view on the binding of alpha-synuclein to synaptic vesicles, which might also affect our understanding of synucleinopathies.
The
self-assembly of normally soluble proteins into fibrillar amyloid
structures is associated with a range of neurodegenerative disorders,
such as Parkinson’s and Alzheimer’s diseases. In the
present study, we show that specific events in the kinetics of the
complex, multistep aggregation process of one such protein, α-synuclein,
whose aggregation is a characteristic hallmark of Parkinson’s
disease, can be followed at the molecular level using optical super-resolution
microscopy. We have explored in particular the elongation of preformed α-synuclein
fibrils; using two-color single-molecule localization microscopy we
are able to provide conclusive evidence that the elongation proceeds
from both ends of the fibril seeds. Furthermore, the technique reveals
a large heterogeneity in the growth rates of individual fibrils; some
fibrils exhibit no detectable growth, whereas others extend to more
than ten times their original length within hours. These large variations
in the growth kinetics can be attributed to fibril structural polymorphism.
Our technique offers new capabilities in the study of amyloid growth
dynamics at the molecular level and is readily translated to the study
of the self-assembly of other nanostructures.
Background: The aggregation and stereotypic spreading of Tau protein is associated with Alzheimer disease.Results: Monomeric Tau enters neurons and nucleates and engages endogenous Tau to aggregate.Conclusion: Endocytosis of soluble Tau triggers aggregation in vesicles and is sufficient to initiate the spreading of pathological species.Significance: Increased levels of extracellular monomeric Tau may increase the risk of developing tauopathies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.